^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    TIMP1-L

    i
    Other names: TIMP1, TIMP metallopeptidase inhibitor 1, CLGI, EPO, TIMP, Erythroid-potentiating activity, Fibroblast collagenase inhibitor, Tissue inhibitor of metalloproteinases 1, EPA
    Entrez ID:
    7076
    Related biomarkers:
    Expression
    2years
    TIMP1 Promotes Cell Proliferation and Invasion Capability of Right-sided Colon Cancers via the FAK/Akt Signaling Pathway. (PubMed, Cancer Sci)
    Our data suggest that TIMP1 is overexpressed in right-sided CRCs and promotes cell proliferation and invasion capability through the TIMP1/FAK/Akt pathway, leading to a poor prognosis. The TIMP1/FAK/Akt pathway can be a target for therapeutic agents in right-sided CRCs.
    Journal
    |
    TIMP1 (Tissue inhibitor of metalloproteinases 1)
    |
    KIM1 expression • TIMP1 expression • TIMP1-L